Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

559
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
559
Hazard Rate01:11

Hazard Rate

312
The hazard rate, also known as the hazard function or failure rate, is a statistical measure used to describe the instantaneous rate at which an event occurs, given that the event has not yet happened. From a probabilistic perspective, it represents the likelihood that a subject will experience the event in a very small time interval, conditional on surviving up to the beginning of that interval. In terms of frequency, the hazard rate can be viewed as the ratio of the number of events to the...
312
Introduction To Survival Analysis01:18

Introduction To Survival Analysis

569
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
569
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

458
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
458
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

292
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
292
Parametric Survival Analysis: Weibull and Exponential Methods01:14

Parametric Survival Analysis: Weibull and Exponential Methods

874
Parametric survival analysis models survival data by assuming a specific probability distribution for the time until an event occurs. The Weibull and exponential distributions are two of the most commonly used methods in this context, due to their versatility and relatively straightforward application.
Weibull Distribution
The Weibull distribution is a flexible model used in parametric survival analysis. It can handle both increasing and decreasing hazard rates, depending on its shape parameter...
874

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Application of integrated nested Laplace approximation to identify hot spots of methylation heterogeneity in healthy individuals from the MAMELI cohort.

Frontiers in genetics·2026
Same author

The Reasons to Get Vaccinated: A Cross-Sectional Study on HPV Vaccination Adherence in a Northern Italian University.

Vaccines·2026
Same author

Neurophenomenology, psychoneuroendocrinoimmunology and epigenetics: towards an integrative framework for understanding the health benefits of art and aesthetic experiences.

Journal of the Royal Society, Interface·2026
Same author

Healing dynamics and surgery in breast cancer: rethinking a timeless challenge in light of advancing therapies and technologies.

Journal of translational medicine·2026
Same author

Expression of antibody-drug conjugate targets in post-mortem samples of breast cancer metastases and normal tissue.

Nature communications·2025
Same author

ctDNA detectability and representativeness in seven body liquids from patients with metastatic breast cancer.

Nature communications·2025

Related Experiment Video

Updated: Dec 9, 2025

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.6K

Interpreting Breast Cancer Survival Data by the Hazard Function: Remarkable Findings from Event Dynamics.

Romano Demicheli1, William Hrushesky2,3, Michael Retsky4

  • 1Unit of Medical Statistics, Biometry and Bioinformatics "Giulio A. Maccacaro", Department of Clinical Sciences and Community Health, University of Milan Campus Cascina Rosa, Fondazione IRCCS Istituto Nazionale Tumori, 20133 Milan, Italy.

Medicina (Kaunas, Lithuania)
|September 16, 2020
PubMed
Summary

The hazard function reveals breast cancer recurrence isn't continuous, suggesting tumor dormancy and surgery-induced acceleration. This analysis aids understanding disease biology and recurrence risk factors.

Keywords:
breast cancerhazard functionmicroscopic metastasis accelerationrecurrence dynamicstumor dormancytumor homeostasis

More Related Videos

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
07:41

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Published on: May 17, 2019

9.3K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.4K

Related Experiment Videos

Last Updated: Dec 9, 2025

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.6K
Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
07:41

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Published on: May 17, 2019

9.3K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.4K

Area of Science:

  • Oncology
  • Biostatistics
  • Cancer Biology

Background:

  • Breast cancer recurrence after mastectomy suggests complex disease dynamics beyond simple continuous growth.
  • Tumor dormancy and metastasis development influence the lag-time between primary tumor removal and recurrence.

Purpose of the Study:

  • To investigate the role of the hazard function in analyzing disease-free survival data in breast cancer.
  • To propose a new paradigm for breast cancer metastatic development based on survival data analysis.

Main Methods:

  • Utilized the hazard function to analyze disease-free survival data in breast cancer patients.
  • Examined local recurrences after mastectomy to understand tumor behavior and metastasis.

Main Results:

  • The hazard function's multipeak pattern indicates discontinuous metastasis development.
  • Evidence supports tumor dormancy and surgery-related acceleration of the metastatic process.
  • Analyses by prognostic factors and treatments align with the proposed metastatic model.

Conclusions:

  • The hazard function is a powerful tool for studying post-surgical breast cancer and operable tumors.
  • This approach provides insights into breast cancer biology, recurrence patterns, and potential interventions.